Spinal 5-HT₃ receptor-mediated antinociception: Possible release of GABA

Keyphrases

• Receptor-mediated 100%
• 5-hydroxytryptamine 100%
• Antinociception 100%
• 5-HT3 Receptor 100%
• Analgesic 66%
• Noxious Stimuli 66%
• 5-HT3 66%
• Non-opioid 33%
• Spinal Cord 33%
• Behavioral Effects 33%
• Methyl 33%
• Nociception 33%
• Opposing Effects 33%
• Rodents 33%
• Substance P 33%
• Mode of Action 33%
• Dorsal Horn Neurons 33%
• Serotonergic 33%
• Inhibitory Effect 33%
• Dose Effect 33%
• Tail-flick Test 33%
• Spontaneous Excitatory Postsynaptic Current (sEPSC) 33%
• Electrophysiological Study 33%
• Receptor Subtypes 33%
• Behavioral Studies 33%
• Selective Agonist 33%
• Selective Antagonist 33%
• Neurokinin-1 Receptor (NK1R) 33%
• Multiple Receptor 33%
• Spinal Analgesia 33%
• 5-HT Receptors 33%
• Primary Afferent Fibers 33%
• Excitatory Amino Acid Transporter 33%
• Electrophysiological Effects 33%
• 5-HT3 Antagonist 33%
• Nociceptive Transmission 33%
• Zacopride 33%
• Inhibitory Amino Acids 33%
• Non-addictive 33%

Neuroscience

• Gamma-Aminobutyric Acid 100%
• Serotonin 3 Receptor 100%
• 5-HT3 Agonists 66%
• Agonist 66%
• N-Methyl-D-Aspartic Acid 66%
• Behavior (Neuroscience) 33%
• Serotonergic 33%
• Tachykinin Receptor 33%
• Substance P 33%
• Amino Acid 33%
• Receptor Subtype 33%
• Excitatory Amino Acid Receptor 33%
• Serotonin 5 Receptor 33%
• Nociception 33%
• 5-HT3 Antagonist 33%
• Zacopride 33%